Leonteq Securities’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Leonteq Securities's RXRX Position: Q3 2026 in Review
Leonteq Securities increased its Recursion Pharmaceuticals (RXRX) stake by 1,172% in Q3 2026, buying an estimated $102K and bringing the position to 32,560 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #598.
Leonteq Securities first reported a position in RXRX in Q1 2024 and has held it in 11 quarters since. The position peaked at $510K in Q4 2025. 341 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Leonteq Securities held 32,560 shares of Recursion Pharmaceuticals worth $134K as of Q3 2026.
- Leonteq Securities bought 30,000 Recursion Pharmaceuticals shares in Q3 2026, an estimated $102K.
- Recursion Pharmaceuticals made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #598 holding.
- Leonteq Securities first reported a position in Recursion Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
- Leonteq Securities's Recursion Pharmaceuticals position peaked at $510K in Q4 2025.
- 341 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.